Healthcare - Biotechnology - NASDAQ - US
$ 4.065
-17.2 %
$ 398 M
Market Cap
-2.38
P/E
BALANCE SHEET
622 M
ASSETS
488 M
LIABILITIES
134 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Alector, Inc.
| Current Assets | 566 M |
| Cash & Short-Term Investments | 549 M |
| Receivables | 0 |
| Other Current Assets | 16.9 M |
| Non-Current Assets | 56 M |
| Long-Term Investments | 0 |
| PP&E | 47.1 M |
| Other Non-Current Assets | 8.96 M |
| Current Liabilities | 178 M |
| Accounts Payable | 3.78 M |
| Short-Term Debt | 16.9 M |
| Other Current Liabilities | 157 M |
| Non-Current Liabilities | 310 M |
| Long-Term Debt | 30.5 M |
| Other Non-Current Liabilities | 279 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 74.6 | 154.3 | 329.2 | 50.0 | 89.6 | 65.5 | 32.5 | 50.8 |
| Short Term Investments | 474.3 | 558.5 | 406.1 | 363.3 | 263.4 | 224.9 | 0 | 0 |
| Receivables | 0 | 2.6 | 7.4 | 0 | 0 | 0 | 200.2 | 0.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Other Current Assets | 16.9 | 11.0 | 7.1 | 16.4 | 8.7 | 5.5 | 0.3 | 0.1 |
| Total Current Assets | 565.8 | 726.4 | 749.7 | 421.5 | 357.4 | 293.2 | 233.0 | 51.2 |
| PP&E | 47.1 | 53.3 | 57.9 | 62.7 | 62.3 | 10.9 | 2.8 | 2.5 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 0 | 0.2 |
| Other Long Term Assets | 9.0 | 6.4 | 5.6 | 2.6 | 0.7 | 2.8 | 0.3 | 0.2 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 621.8 | 787.6 | 814.7 | 488.3 | 421.9 | 308.4 | 236.1 | 54.1 |
| LIABILITIES | ||||||||
| Accounts Payable | 3.8 | 4.2 | 4.7 | 3.0 | 0.3 | 0.1 | 1.1 | 1.2 |
| Short Term Debt | 16.9 | 8.1 | 15.6 | 15.0 | 13.1 | 0 | 0 | 0 |
| Other Current Liabilities | 74.3 | 33.3 | 28.4 | 26.2 | 18.4 | 12.9 | 7.3 | 0.4 |
| Total Current Liabilities | 177.9 | 45.6 | 48.2 | 44.2 | 31.8 | 13.0 | 27.4 | 1.5 |
| Long Term Debt | 30.5 | 35.3 | 39.8 | 43.7 | 41.5 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0.5 | 0 | (194.9) | 0 | 0 | 0 |
| Other Liabilities | 68.4 | 0.8 | 0.2 | 0.5 | 0.5 | 7.6 | 77.5 | 77.5 |
| Total Liabilities | 487.7 | 573.2 | 513.9 | 220.7 | 227.2 | 405.8 | 288.1 | 79.0 |
| EQUITY | ||||||||
| Common Stock | 8 K | 8 K | 8 K | 8 K | 7 K | 1 K | 1 K | 0 |
| Retained Earnings | (710.1) | (579.7) | (446.4) | (410.0) | (219.8) | (114.4) | (62.2) | (29.7) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (4.6) | (0.9) | 0.6 | 0.1 | 42 K | (1.0) | (0.3) |
| Total Equity | 134.2 | 214.4 | 300.7 | 267.5 | 194.7 | (97.4) | (52.0) | (24.9) |
| Total Liabilities and Equity | 621.8 | 787.6 | 814.7 | 488.3 | 421.9 | 308.4 | 236.1 | 54.1 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 83.7 | 82.5 | 80.4 | 77.8 | 61.7 | 68.4 | 51.2 | 51.2 |